Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology. Global|March 17, 2025
Multicenter food protein-induced enterocolitis syndrome (FPIES) data collection: Leveraging a REDCap FPIES registry for improved clinical outcomesAnkona Banerjee, J Andrew Bird, Amy M Scurlock, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 6, 2026
Vaccination for Patients With Immunosuppression and Altered Immunity: A Workgroup Report from the AAAAI Adverse Reactions to Drugs, Biologics, and Vaccines Committee and the Autoimmunity and Altered Immune Response CommitteeMildred Kwan, Blanka M Kaplan, Krista Shaw, et al.
The Journal of Allergy and Clinical Immunology|November 9, 2024
Current status and future directions in food protein-induced enterocolitis syndrome: An NIAID workshop report of the June 22, 2022, virtual meetingAnna Nowak-Wegrzyn, Scott H Sicherer, Cem Akin, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 18, 2026
Age-Appropriate Low Dosing for FPIES Oral Food Challenges: Proposing a Standardized ApproachSara Anvari, Mary Grace Baker, Theresa Bingemann, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 1, 2025
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 1, 2021
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial ResultsJacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, et al.
The Journal of Allergy and Clinical Immunology. Global|September 29, 2023
The SunBEAm birth cohort: Protocol designCorinne Keet, Scott H Sicherer, Supinda Bunyavanich, et al.
The Journal of Allergy and Clinical Immunology|July 14, 2020
Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year resultsDavid M Fleischer, Wayne G Shreffler, Dianne E Campbell, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 16, 2025
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPEMatthew Greenhawt, Deborah Albright, Sara Anvari, et al.
Pageof 7